Smolen JS - Search Results

1

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, Keystone E, Schiff M, Kalden JR, Wang B, Dewoody K, Weiss R, Baker D; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. St Clair EW, et al. Among authors: smolen js. Arthritis Rheum. 2004 Nov;50(11):3432-43. doi: 10.1002/art.20568. Arthritis Rheum. 2004. PMID: 15529377 Clinical Trial.

2

Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay.

Menzel J, Steffen C, Kolarz G, Kojer M, Smolen J. Menzel J, et al. Arthritis Rheum. 1978 Mar;21(2):243-8. doi: 10.1002/art.1780210212. Arthritis Rheum. 1978. PMID: 637891

3

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Machold KP, Neumann K, Smolen JS. Machold KP, et al. Among authors: smolen js. Ann Rheum Dis. 1992 Sep;51(9):1039-43. doi: 10.1136/ard.51.9.1039. Ann Rheum Dis. 1992. PMID: 1417133 Free PMC article. Clinical Trial.

4

Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study.

Knobler RM, Graninger W, Graninger W, Lindmaier A, Trautinger F, Smolen JS. Knobler RM, et al. Among authors: smolen js. Arthritis Rheum. 1992 Mar;35(3):319-24. doi: 10.1002/art.1780350311. Arthritis Rheum. 1992. PMID: 1536670 Clinical Trial.

5

Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis.

Hassfeld W, Steiner G, Hartmuth K, Kolarz G, Scherak O, Graninger W, Thumb N, Smolen JS. Hassfeld W, et al. Among authors: smolen js. Arthritis Rheum. 1989 Dec;32(12):1515-20. doi: 10.1002/anr.1780321204. Arthritis Rheum. 1989. PMID: 2597207

6

Oral gold therapy in a patient with rheumatoid arthritis and preexisting uremia.

Graninger W, Seidl G, Kovarik J, Pinggera W, Smolen JS. Graninger W, et al. Among authors: smolen js. Arthritis Rheum. 1985 Jun;28(6):710-2. doi: 10.1002/art.1780280618. Arthritis Rheum. 1985. PMID: 3924061 No abstract available.

7

Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis.

Smolen JS, Menzel EJ, Scherak O, Kojer M, Kolarz G, Steffen C, Mayr WR. Smolen JS, et al. Arthritis Rheum. 1980 Apr;23(4):424-31. doi: 10.1002/art.1780230405. Arthritis Rheum. 1980. PMID: 6966152

8

A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial.

Wylie G, Appelboom T, Bolten W, Breedveld FC, Feely J, Leeming MR, Le Loët X, Manthorpe R, Marcolongo R, Smolen J. Wylie G, et al. Br J Rheumatol. 1995 Jun;34(6):554-63. doi: 10.1093/rheumatology/34.6.554. Br J Rheumatol. 1995. PMID: 7543348 Clinical Trial.

9

Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.

Leeb BF, Witzmann G, Ogris E, Studnicka-Benke A, Andel I, Schweitzer H, Smolen JS. Leeb BF, et al. Among authors: smolen js. Clin Exp Rheumatol. 1995 Jul-Aug;13(4):459-63. Clin Exp Rheumatol. 1995. PMID: 7586777 Clinical Trial.

10

Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.

Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, Smolen JS. Hassfeld W, et al. Among authors: smolen js. Arthritis Rheum. 1995 Jun;38(6):777-85. doi: 10.1002/art.1780380610. Arthritis Rheum. 1995. PMID: 7779120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results